<DOC>
	<DOC>NCT01553617</DOC>
	<brief_summary>The study will compare the efficacy and safety of VolulyteTM and human albumin in elective open-heart surgery in adult patients.</brief_summary>
	<brief_title>VolulyteTM in Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>male or female adult patients undergoing primary elective cardiac surgery applying extracorporeal circulation signed written informed consent known contraindication against scheduled medication preoperative acute normovolaemic haemodilution or preoperative autologous blood donation planned systemic hypothermia (body temperature &lt; 30°C) expected time on ECC ≥ 2 hours</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>